- Home
- MRNA vs KEYS Comparison
MRNA vs KEYS Comparison
Compare MRNA & KEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | KEYS |
|---|---|---|
| Founded | 2010 | 1939 |
| Country | United States | United States |
| Employees | N/A | 16600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 60.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MRNA | KEYS |
|---|---|---|
| Price | $198.47 | $357.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $34.27 | ★ $287.00 |
| AVG Volume (30 Days) | ★ 13.5M | 873.7K |
| Earning Date | 05-01-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.77 | ★ 39.89 |
| EPS | N/A | ★ 5.93 |
| Revenue | ★ $19,263,000,000.00 | $5,375,000,000.00 |
| Revenue This Year | $9.36 | $25.49 |
| Revenue Next Year | $15.43 | $8.17 |
| P/E Ratio | ★ N/A | $60.68 |
| Revenue Growth | 4.29 | ★ 7.95 |
| 52 Week Low | $22.28 | $159.01 |
| 52 Week High | $202.67 | $374.96 |
Technical Indicators
Market Signals| Indicator | MRNA | KEYS |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 62.63 |
| Support Level | $43.35 | $306.45 |
| Resistance Level | N/A | $367.77 |
| Average True Range (ATR) | 11.47 | 8.97 |
| MACD | 2.59 | 3.61 |
| Stochastic Oscillator | 86.71 | 82.97 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About KEYS Keysight Technologies Inc.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.